In this study, we examined this hypothesis to determine whether delphinidin enhances the therapeutic potential of TRAIL and induces apoptosis of TRAIL-resistant prostate cancer LNCaP cells. This evidence concerns the gene TNFSF10 and prostate carcinoma.